Isosorbide mononitrate and Zanaflex drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Isosorbide mononitrate (isosorbide mononitrate) and Zanaflex (tizanidine hydrochloride). Common drug interactions include sepsis among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Isosorbide mononitrate and Zanaflex. It is created by eHealthMe based on reports of 53 people who take the same drugs from the FDA, and is updated regularly.

What is Isosorbide mononitrate?

Isosorbide mononitrate has active ingredients of isosorbide mononitrate. It is often used in angina. eHealthMe is studying from 26,858 Isosorbide mononitrate users. Check the latest studies of Isosorbide mononitrate.

What is Zanaflex?

Zanaflex has active ingredients of tizanidine hydrochloride. It is often used in muscle spasms. eHealthMe is studying from 17,476 Zanaflex users. Check the latest studies of Zanaflex.



On Jul, 06, 2026

53 people who take Isosorbide mononitrate and Zanaflex together, and have interactions are studied.

Isosorbide mononitrate and Zanaflex drug interactions.

What are the common drug interactions of Isosorbide Mononitrate and Zanaflex, by gender? *:

female:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Back pain
  3. Activities of daily living impaired
  4. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  5. Acute left ventricular failure (heart attack)
  6. Acute myocardial infarction (acute heart attack)
  7. Acute respiratory failure
  8. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  9. Anxiety
  10. Apathy

male:

  1. Arthralgia (joint pain)
  2. Head injury
  3. Headache (pain in head)
  4. Influenza
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Acute respiratory failure
  7. Adverse event
  8. Blood cholesterol increased
  9. Blood glucose decreased
  10. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the common drug interactions of Isosorbide Mononitrate and Zanaflex, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Constipation
  2. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  3. Haematemesis (vomiting of blood)
  4. Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
  5. Rectal haemorrhage (bleeding from anus)

40-49:

  1. Constipation

50-59:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Acute myocardial infarction (acute heart attack)
  3. Acute respiratory failure
  4. Adverse event
  5. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  6. Blood creatinine increased
  7. Breast cancer
  8. Cardiac disorder
  9. Chest discomfort
  10. Chest pain

60+:

  1. Chest pain
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Cellulitis (infection under the skin)
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
  6. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  7. Embolism venous (embolus may pass into the arterial system)
  8. Essential hypertension (primary hypertension)
  9. Fall
  10. Hypercholesterolaemia (high levels of cholesterol in the blood)

What are the existing conditions these people have? *

  1. Pain: 17 people, 32.08%
  2. High Blood Pressure: 10 people, 18.87%
  3. Cardiac Disorder: 8 people, 15.09%
  4. Depression: 8 people, 15.09%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 15.09%
  6. Multiple Myeloma (cancer of the plasma cells): 6 people, 11.32%
  7. Cough: 6 people, 11.32%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 6 people, 11.32%
  9. Neuropathy Peripheral (surface nerve damage): 6 people, 11.32%
  10. High Blood Cholesterol: 6 people, 11.32%

* Approximation only. Some reports may have incomplete information.

Do you take Isosorbide mononitrate and Zanaflex?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Isosorbide mononitrate and Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Isosorbide mononitrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zanaflex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Isosorbide mononitrate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zanaflex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isosorbide mononitrate and tizanidine hydrochloride (the active ingredients of Isosorbide mononitrate and Zanaflex, respectively), and Isosorbide mononitrate and Zanaflex (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: